BACTERIAL VAGINOSIS
Clinical trials for BACTERIAL VAGINOSIS explained in plain language.
Never miss a new study
Get alerted when new BACTERIAL VAGINOSIS trials appear
Sign up with your email to follow new studies for BACTERIAL VAGINOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New bacterial vaginosis drug candidate enters first human safety trial
Disease control Not yet recruitingThis early-stage trial tests a new drug called GenSci142 for bacterial vaginosis, a common vaginal infection. It will involve 30 healthy Chinese women to check the drug's safety and how the body processes it. The study is not yet recruiting and is the first step in seeing if this…
Matched conditions: BACTERIAL VAGINOSIS
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
New combo therapy aims to end recurring vaginal infections
Prevention Not yet recruitingThis study tests whether taking BPR-101 capsules along with standard antibiotic treatment can prevent bacterial vaginosis (BV) from returning. About 80 women with BV will receive either the study drug or a placebo. The goal is to see if the combination reduces the chance of BV co…
Matched conditions: BACTERIAL VAGINOSIS
Phase: PHASE2 • Sponsor: Chengdu Syncor Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated May 26, 2026 07:24 UTC
-
Milk protein could end antibiotic overuse for common vaginal infections
Symptom relief Not yet recruitingThis study tests whether lactoferrin, a natural prebiotic from cow's milk, can be an acceptable alternative to antibiotics for women with bacterial vaginosis or thrush. About 114 women will use either lactoferrin vaginal pessaries or standard antibiotic/antifungal tablets. The go…
Matched conditions: BACTERIAL VAGINOSIS
Phase: NA • Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC